Your weekly roundup of the latest news from Drug Topics®.
With supply chain issues impacting many industries, drug shortages have occurred. How does the FDA address them?
Israeli researchers find more than fivefold risk of developing systemic sclerosis among people with vitiligo.
New research indicates that glucose monitoring could lead to lifestyle changes during prediabetes.
Addressing the 2 inflammatory conditions requires careful consideration of the therapies to use.
This is the first FDA-approved ADC for platinum-resistant disease, according to ImmunoGen.
How Differences in Bispecific Therapies Impact Myeloma Treatment Operations
April 18th 2024According to Kirollos Hanna, PharmD, although similarities exist between bispecific therapies in the myeloma space, health care providers should take special note of practical differences and nuances associated with each when operationalizing them at their site of care.